Stefanie Wagner
Affiliations: | 2013- | Helmholtz Institute for Pharmaceutical Research Saarland |
Google:
"Stefanie Wagner"Parents
Sign in to add mentor| Guy R. Cornelis | grad student | Biozentrum, University of Basel | |
| Alexander Titz | post-doc | 2013-2021 | Helmholtz Institute for Pharmaceutical Research Saarland |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bublitz A, Brauer M, Wagner S, et al. (2023) The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection. Cell Host & Microbe |
| Sänger PA, Wagner S, Liebler-Tenorio EM, et al. (2022) Dissecting the invasion of Galleria mellonella by Yersinia enterocolitica reveals metabolic adaptations and a role of a phage lysis cassette in insect killing. Plos Pathogens. 18: e1010991 |
| Meiers J, Zahorska E, Röhrig T, et al. (2020) Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates targeting Biofilm-associated Lectins of Pseudomonas aeruginosa. Journal of Medicinal Chemistry |
| Sommer R, Rox K, Wagner S, et al. (2019) Anti-Biofilm Agents against Pseudomonas aeruginosa: a Structure-Activity Relationship Study of C-Glycosidic LecB Inhibitors. Journal of Medicinal Chemistry |
| Sommer R, Wagner S, Rox K, et al. (2017) Glycomimetic, orally bioavailable LecB inhibitors block biofilm formation of Pseudomonas aeruginosa. Journal of the American Chemical Society |
| Beshr G, Sikandar A, Jemiller EM, et al. (2017) Photorhabdus luminescens lectin A (PllA) - a new probe for detecting α-galactoside-terminating glycoconjugates. The Journal of Biological Chemistry |
| Wagner S, Hauck D, Hoffmann M, et al. (2017) Covalent lectin inhibition and application in bacterial biofilm imaging. Angewandte Chemie (International Ed. in English) |
| Torge A, Wagner S, Chaves PS, et al. (2017) Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis. International Journal of Pharmaceutics |
| Sommer R, Wagner S, Varrot A, et al. (2016) The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chemical Science. 7: 4990-5001 |
| Wagner S, Sommer R, Hinsberger S, et al. (2016) Novel Strategies for the treatment of Pseudomonas aeruginosa infections. Journal of Medicinal Chemistry |